Nordea Investment Management Ab Nektar Therapeutics Transaction History

Nordea Investment Management Ab

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$10.83 - $18.41 $345,097 - $586,634	-31,865 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$13.07 - $18.84 $416,475 - $600,336	-31,865 Reduced 50.0%	31,865 $578,000
Q3 2021 Nov 01, 2021	BUY	$13.07 - $18.84 $416,475 - $600,336	31,865 Added 100.0%	63,730 $1.14 Million
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $11,343 - $17,440	685 Added 2.2%	31,865 $633,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $41,995 - $50,676	2,663 Added 9.34%	31,180 $530,000
Q3 2020 Nov 09, 2020	SELL	$16.59 - $24.79 $473,097 - $706,936	-28,517 Reduced 50.0%	28,517 $478,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $481,336 - $669,188	28,549 Added 100.22%	57,034 $1.32 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $2,025 - $3,914	-140 Reduced 0.49%	28,485 $504,000
Q4 2019 Feb 11, 2020	SELL	$15.87 - $23.12 $107,693 - $156,892	-6,786 Reduced 19.16%	28,625 $605,000
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $203,019 - $237,728	6,549 Added 22.69%	35,411 $1.26 Million
Q1 2019 May 20, 2019	BUY	$31.58 - $46.35 $676,506 - $992,909	21,422 Added 287.93%	28,862 $971,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $7,619 - $11,232	164 Added 2.25%	7,440 $453,000
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $261,081 - $589,620	5,645 Added 346.11%	7,276 $355,000
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $93,619 - $176,865	1,631 New	1,631 $173,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.